Cargando…
Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis
BACKGROUND: Advanced pancreatic cancer confers poor prognosis and treatment advancement has been slow. Recent randomized clinical trials (RCTs) have demonstrated survival benefits for combination therapy compared to gemcitabine alone. However, the comparative benefits and harms of available combinat...
Autores principales: | Gresham, Gillian K, Wells, George A, Gill, Sharlene, Cameron, Christopher, Jonker, Derek J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097092/ https://www.ncbi.nlm.nih.gov/pubmed/24972449 http://dx.doi.org/10.1186/1471-2407-14-471 |
Ejemplares similares
-
The Efficacy of Different Chemotherapy Regimens for Advanced Biliary Tract Cancer: A Systematic Review and Network Meta-Analysis
por: Li, Yan, et al.
Publicado: (2019) -
A network meta-analysis of eight chemotherapy regimens for treatment of advanced ovarian cancer
por: Jiang, Xi-Ping, et al.
Publicado: (2016) -
Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan: A Systematic Review and Network Meta-analysis
por: Takumoto, Yuki, et al.
Publicado: (2022) -
Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
por: Wu, Dong-Mei, et al.
Publicado: (2017) -
The optimal neoadjuvant chemotherapy regimen for locally advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and Bayesian network meta-analysis
por: Wang, Tongya, et al.
Publicado: (2022)